CHRIS BISHOP (National): Sorry, I thought my colleague Andrew Bayly was seeking a call, but, in fact, he's skedaddling. So two questions following on from my previous remarks, and they relate to Part 1, or New Schedule 1AA, which amends Part 1 in relation to the validation. The first is, when the Cabinet was considering the roll-out of the COVID-19 vaccines, particularly the Pfizer vaccine in relation to the Cabinet papers, did those Cabinet papers identify any legal risk and was this prospect identified as a legal risk? And secondly, when did Cabinet first turn its mind to the possibility that the legislation that we're debating might be required?